Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China · Delayed Price · Currency is CNY 47.44
-2.06 (-4.16%)
Nov 17, 2025, 2:15 PM CST
SHA:600329 Revenue
Tianjin Pharmaceutical Da Ren Tang Group Corporation had revenue of 1.02B CNY in the quarter ending September 30, 2025, a decrease of -38.08%. This brings the company's revenue in the last twelve months to 5.37B, down -33.26% year-over-year. In the year 2024, Tianjin Pharmaceutical Da Ren Tang Group Corporation had annual revenue of 7.31B, down -11.14%.
Revenue (ttm)
5.37B
Revenue Growth
-33.26%
P/S Ratio
6.06
Revenue / Employee
1.16M
Employees
4,619
Market Cap
32.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.31B | -915.58M | -11.14% |
| Dec 31, 2023 | 8.22B | -26.94M | -0.33% |
| Dec 31, 2022 | 8.25B | 1.34B | 19.42% |
| Dec 31, 2021 | 6.91B | 303.89M | 4.60% |
| Dec 31, 2020 | 6.60B | -390.23M | -5.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |